Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Athroa Innovations is a private Athens-based venture builder and micro-holding company that develops and operates IP-driven early-stage ventures focused on human and planetary health challenges. The company works with inventors and founders globally, providing pre-seed funding, operational support, IP protection, business development, fundraising, and staffing to advance spinouts toward market readiness. Its disclosed health-related portfolio and past projects include a wearable blood pressure monitoring device, blood-brain-barrier-crossing small molecules for neurodegenerative disease, a DNA screening test for severe COVID-19 triage, and an imaging-related drug-carrier labeling technology. Athroa appears to operate more as a venture creation platform than as a single-asset therapeutics company, with activity spanning biomedical, clean-tech, and food-tech inventions. Publicly available information suggests it remains active and privately held.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Athroa Innovations.